the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Malaysia to launch new refugee registration system from January 2026

Malaysia will implement the Refugee Registration Document system from Jan 1, 2026, replacing UNHCR management to enhance security and data control.

KUALA LUMPUR: The government will implement the Refugee Registration Document system from January 1, 2026.

Deputy Home Minister Datuk Seri Dr Shamsul Anuar Nasarah announced this initiative to address security risks and disorganised data.

The system replaces the current registration managed solely by the United Nations High Commissioner for Refugees.

“This situation causes the government to not have any element of control over the individual’s application as refugee, their total and their location in Malaysia,” he told Parliament.

Shamsul Anuar said refugee information and biometrics will be stored in the new government system.

Confirmed refugees will receive an official identification document recognised by Malaysian authorities.

The measure enables comprehensive government monitoring and more effective refugee management.

He noted the current UNHCR system operates without government agency involvement.

This has led to cases of disorganised registration, abuse and document falsification.

The DPP system is currently in testing to ensure stability before official launch.

Refugee data will remain in government biometric systems until final management decisions.

These include third-country settlement, origin country repatriation, or deportation for law violations.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings